Startup · $5.2m raised
Programs: ANDHealth (ANDHealth+) · Brandon BioCatalyst (CUREator+) · CUREator+ (CUREator+)
Every investor coverage indicates participated in a round Neurotologix raised.
| Investor | Rounds | Invested |
|---|---|---|
| Brandon BioCatalyst | Accelerator · Grant | - |
| CUREator+ | Accelerator · Grant | - |
| Medical Research Future Fund | Grant · Grant | - |
| ANDHealth | Grant | - |
Companies Neurotologix acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Kate Lewkowski | CEO | Startup News (WA) |
Stories naming Neurotologix. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Six Australian health tech startups received non-dilutive grants totaling $13.5 million from the government-backed CUREator+ program to accelerate commercialisation of medical innovations.
Six Australian biomedical and health ventures receive a combined $13.5 million in non-dilutive grants through round two of the CUREator+ commercialisation program operated by Brandon BioCatalyst and backed by the Medical Research Future Fund.
Also Dealroom
Six Australian health tech startups received a combined $13.5 million in non-dilutive funding from the CUREator+ program, supported by the Australian Government.
CUREator+ granted thirteen point five million dollars in non-dilutive funding to six Australian health tech startups to support commercialisation of medical innovations.
Roundup of Australian manufacturing news: OncoSil, K-TIG and Aurora Labs complete or commit raises, Amplia opens an offer, Siemens agrees to buy Altair, CSIRO unveils a printed-solar facility, and a WA medical alliance grows.
Western Australia's government has awarded $8.5 million in grants across three schemes, a health innovation seed fund, commercialisation bridge grants and innovation booster grants, naming dozens of local recipients.
Roundup of seven Australian startups landing fresh capital and grants: Gaia EnviroTech's $4.3 million deal with RFM, four medtechs sharing $3.25 million via ANDHealth+, Q-CTRL's UK quantum prize, and CarbonHQ's $600,000 pre-seed.
Four Australian medtech companies have received a share of $3.25 million through the ANDHealth+ program, with the money aimed at clinical milestones and global expansion.
Also SmartCompany
Over thirty Australian projects received federal Accelerating Commercialisation grants totalling roughly $18 million, including Jevons Robotics, Glaciem, Electrogenics and LYRO Robotics, with the full recipient list published.
Also @AuManufacturing·Startup Daily·@AuManufacturing·@AuManufacturing